BR9916042A - Composto, composição farmacêutica, e, processospara inibir a replicação de um vìrus herpes, e detratamento de um paciente que sofra de umainfecção do vìrus herpes - Google Patents
Composto, composição farmacêutica, e, processospara inibir a replicação de um vìrus herpes, e detratamento de um paciente que sofra de umainfecção do vìrus herpesInfo
- Publication number
- BR9916042A BR9916042A BR9916042-0A BR9916042A BR9916042A BR 9916042 A BR9916042 A BR 9916042A BR 9916042 A BR9916042 A BR 9916042A BR 9916042 A BR9916042 A BR 9916042A
- Authority
- BR
- Brazil
- Prior art keywords
- carbon atoms
- alkyl
- herpes virus
- heteroaryl
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/22—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, PROCESSOSPARA INIBIR A REPLICAçãO DE UM VìRUS HERPES, E DETRATAMENTO DE UM PACIENTE QUE SOFRA DE UMAINFECçãO DO VìRUS HERPES". Os compostos da fórmula (1),em que R~ 1~ a R~ 5~ são independentemente selecionados dehidrogênio, alquila de 1 a 6 átomos de carbono, alquenila de 2 a 6átomos de carbono, alquinila de 2 a 6 átomos de carbono,per-haloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10átomos de carbono, heterocicloalquila de 3 a 10 membros decarbono, arila, heteroarila, halógeno, -CN, -NO~ 2~, -CO~ 2~R~6~, -COR~ 6~, -OR~ 6~ -SR~ 6~, -SOR~ 6~, -SO~ 2~R~ 6~,-CON~ 7~R~ 8~, NR~ 6~N(R~ 7~R~ 8~), -N(R~ 7~R~ 8~) ouW-Y-(CH~ 2~)~ n~-Z; ou R~ 2~ e R~ 3~ ou R~ 3~ e R~ 4~,tomados juntos de uma heterocicloalquila de 3 a 7 membros, ouheteroarila de 3 a 7 membros; R~ 6~ e R~ 7~ sãoindependentemente hidrogênio, alquila de 1 a 6 átomos decarbono, per-haloalquila de 1 a 6 átomos de carbono, ou arila; R~8~ é hidrogênio, alquila de 1 a 6 átomos de carbono,per-haloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10átomos de carbono, heterocicloalquila de 3 a 10 membros, arila ouheteroarila, ou R^ 7^ e R^ 8^ tomados juntos podem formar umaheterocicloalquila de 3 a 7 membros; A é heteroarila; W é 0, NR~6~, ou está ausente; Y é -(CO)- ou -(CO~ 2~)-, ou está ausente; Zé alquíla de 1 a 4 átomos de carbono, -CN, -CO~ 2~R~ 6~ COR~6~, CONR~ 7~R~ 8~, -OCOR~ 6~, -NR~ 6~COR~ 7~, -OCONR~6~, -OR~ 6~, -SR~ 6~, -SOR~ 6~, -SO~ 2~R~ 6~, SR~ 6~N(R~7~R~ 8~), -N(R~ 7~R~ 8~) ou fenila; G é arila ou heteroarila; X éuma ligação, NH, alquila de 1 a 6 átomos de carbono, alquenila de1 a 6 átomos de carbono, alcóxi de 1 a 6 átomos de carbono, outioalquila de 1 a 6 átomos de carbono, alquilamino de 1 a 6 átomosde carbono, ou (CH)J; J é alquila de 1 a 6 átomos de carbono,cicloalquila de 3 a 7 átomos de carbono, fenila ou benzila; e n é umnúmero inteiro de 1 a 6, útil no tratamento de doenças associadascom os vírus herpes, incluindo o citomegalovírus humano, o vírusdo herpes simplex, o vírus Epstein-Barr, o vírus varicela-zoster, oherpesvírus humano 6 e 7,1 e o herpesvírus de Kaposi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20854098A | 1998-12-09 | 1998-12-09 | |
PCT/US1999/028892 WO2000034269A1 (en) | 1998-12-09 | 1999-12-06 | Thiourea inhibitors of herpes viruses |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9916042A true BR9916042A (pt) | 2001-12-04 |
Family
ID=22774965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9916042-0A BR9916042A (pt) | 1998-12-09 | 1999-12-06 | Composto, composição farmacêutica, e, processospara inibir a replicação de um vìrus herpes, e detratamento de um paciente que sofra de umainfecção do vìrus herpes |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1140913A1 (pt) |
JP (1) | JP2002531558A (pt) |
KR (1) | KR20010086082A (pt) |
CN (1) | CN1335843A (pt) |
AU (1) | AU756043B2 (pt) |
BG (1) | BG105580A (pt) |
BR (1) | BR9916042A (pt) |
CA (1) | CA2351390A1 (pt) |
CZ (1) | CZ20011958A3 (pt) |
EA (1) | EA200100637A1 (pt) |
HU (1) | HUP0104758A3 (pt) |
ID (1) | ID29064A (pt) |
IL (1) | IL143203A0 (pt) |
NO (1) | NO20012836L (pt) |
PL (1) | PL348177A1 (pt) |
SK (1) | SK7692001A3 (pt) |
TR (1) | TR200101598T2 (pt) |
ZA (1) | ZA200104373B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000055152A1 (en) * | 1999-03-12 | 2000-09-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aromatic heterocyclic compounds as anti-inflammatory agents |
JP3938651B2 (ja) * | 2000-04-13 | 2007-06-27 | セントラル硝子株式会社 | 光学活性α−メチル−ビス−3、5−(トリフルオロメチル)ベンジルアミンの製造方法 |
WO2005000795A2 (en) * | 2003-06-10 | 2005-01-06 | Smithkline Beecham Corporation | Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
EP1928847A4 (en) * | 2005-08-29 | 2011-08-10 | Gerard M Housey | THERAMUTEINE MODULATORS |
CN108642926B (zh) * | 2018-04-26 | 2023-11-14 | 浙江汉邦新材料股份有限公司 | 一种涤纶染色清洗用的硫脲衍生物及其制备方法 |
WO2021100730A1 (ja) * | 2019-11-19 | 2021-05-27 | 武田薬品工業株式会社 | ピロリジン化合物の製造方法 |
-
1999
- 1999-12-06 PL PL99348177A patent/PL348177A1/xx not_active Application Discontinuation
- 1999-12-06 ID IDW00200101230A patent/ID29064A/id unknown
- 1999-12-06 JP JP2000586716A patent/JP2002531558A/ja active Pending
- 1999-12-06 CN CN99815807A patent/CN1335843A/zh active Pending
- 1999-12-06 AU AU31122/00A patent/AU756043B2/en not_active Ceased
- 1999-12-06 IL IL14320399A patent/IL143203A0/xx unknown
- 1999-12-06 TR TR2001/01598T patent/TR200101598T2/xx unknown
- 1999-12-06 EP EP99965143A patent/EP1140913A1/en not_active Withdrawn
- 1999-12-06 EA EA200100637A patent/EA200100637A1/ru unknown
- 1999-12-06 BR BR9916042-0A patent/BR9916042A/pt not_active Application Discontinuation
- 1999-12-06 KR KR1020017007051A patent/KR20010086082A/ko not_active Application Discontinuation
- 1999-12-06 HU HU0104758A patent/HUP0104758A3/hu unknown
- 1999-12-06 CA CA002351390A patent/CA2351390A1/en not_active Abandoned
- 1999-12-06 CZ CZ20011958A patent/CZ20011958A3/cs unknown
- 1999-12-06 SK SK769-2001A patent/SK7692001A3/sk unknown
-
2001
- 2001-05-28 ZA ZA200104373A patent/ZA200104373B/en unknown
- 2001-06-08 NO NO20012836A patent/NO20012836L/no not_active Application Discontinuation
- 2001-06-08 BG BG105580A patent/BG105580A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
AU756043B2 (en) | 2003-01-02 |
ID29064A (id) | 2001-07-26 |
EA200100637A1 (ru) | 2001-12-24 |
CN1335843A (zh) | 2002-02-13 |
HUP0104758A2 (hu) | 2002-04-29 |
AU3112200A (en) | 2000-06-26 |
IL143203A0 (en) | 2002-04-21 |
SK7692001A3 (en) | 2002-09-10 |
PL348177A1 (en) | 2002-05-06 |
NO20012836L (no) | 2001-08-08 |
CA2351390A1 (en) | 2000-06-15 |
EP1140913A1 (en) | 2001-10-10 |
KR20010086082A (ko) | 2001-09-07 |
BG105580A (bg) | 2002-01-31 |
NO20012836D0 (no) | 2001-06-08 |
JP2002531558A (ja) | 2002-09-24 |
HUP0104758A3 (en) | 2002-05-28 |
CZ20011958A3 (cs) | 2001-10-17 |
TR200101598T2 (tr) | 2001-10-22 |
ZA200104373B (en) | 2002-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9916041A (pt) | Composto, composição farmacêutica, e, métodospara inibir a replicação de um vìrus do herpes epara tratar um paciente sofrendo de uma infecçãopor vìrus do herpes | |
WO1998056761A3 (en) | Benzimidazole derivatives | |
EA200000990A1 (ru) | Вич-ингибирующие производные пиримидина | |
BR9905109A (pt) | "compostos farmaceuticamente ativos" | |
EA200000993A1 (ru) | Тризамещенные производные 1,3,5-триазина для лечения вич-инфекционных заболеваний | |
MY117892A (en) | Therapeutic compounds | |
BR0004786A (pt) | Compostos farmaceuticamente ativos | |
BR9916086A (pt) | Composto, composição farmacêutica, método para inibir a replicação de um vìrus do herpes, método para tratar um paciente sofrendo de uma infecção por vìrus do herpes | |
BR9916046A (pt) | Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus herpes e para tratamento de um paciente que sofra de uma infecção do vìrus herpes | |
BR9916042A (pt) | Composto, composição farmacêutica, e, processospara inibir a replicação de um vìrus herpes, e detratamento de um paciente que sofra de umainfecção do vìrus herpes | |
BR9916084A (pt) | Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus da herpes, e para tratar um paciente sofrendo de uma infecção por vìrus da herpes | |
NZ338108A (en) | Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infections using roscovitine and olomoucine | |
MX9805441A (es) | Compuestos terapeuticos. | |
GR3032274T3 (en) | Prostaglandin derivatives | |
EA200100639A1 (ru) | Производные тиомочевины, содержащие гетероциклический карбоксамид и защитную группу фенилэтиленамина, в качестве ингибиторов вирусов герпеса | |
HUP0104611A2 (hu) | Herpeszvírus inhibitor hatású tiokarbamid származékok és ezeket tartalmazó gyógyszerkészítmények | |
ES2134441T3 (es) | Benzonitrilos terapeuticos. | |
DK0728002T3 (da) | Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner | |
GR3019075T3 (en) | Inhibitor of herpes simplex viral thymidine kinase | |
DK0728001T3 (da) | Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 6-infektioner | |
AU4989099A (en) | Preparation and use of sulfur-containing phosphonoformate derivatives and analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |